Immunogenicity & Antigenicity-Based T-Cell & Epitopes Identification for Design of Biologic Therapeutics
Time: 10:00 am
day: Day One
Details:
- In silico analysis as an integrative approach for the assessment of immunogenicity in the pre-clinical phase
- In vitro validation study to offer predictive insights on immunogenicity of biotherapeutics
- Remaining challenges to offer better predictive insights to mitigate clinical immunogenicity risk of biotherapeutics
